Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen - Wikidata - wikimedia - TriplyDB

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

http://www.wikidata.org/entity/Q34564174

about

Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.Complement membrane attack complex is related with immune-mediated necrotizing myopathy.Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma Myositis-specific autoantibodies: detection and clinical associations.The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan Developments in the scientific and clinical understanding of inflammatory myopathies.Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis.Cutting edge issues in polymyositis.Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features.Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies.Autoantibodies in polymyositis and dermatomyositis.A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Integrated classification of inflammatory myopathies.Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.Polymyositis and dermatomyositis: Disease spectrum and classification.Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.Idiopathic inflammatory myopathies overlapping with systemic diseases.Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.

P2860

Q33293736-E1ED1B02-B78D-4380-BBF7-0C35E5D3BEE0 Q34029161-0A572666-47CD-4662-BFA4-9759E71E14F8 Q34660484-A1BB592D-4BAA-4D59-91B4-1C9916F48312 Q35309808-0D6AC0D5-4615-49CF-8DD4-8C71DC29B919 Q36013885-31C99710-B411-44E1-81FA-91EB1061C91A Q36559044-6706D6BA-029F-40C3-8CD4-105F284AAC93 Q37306840-8E8965B5-D199-4D7F-A95D-ECDCA90B59AD Q37704799-3118B83D-F7F6-490B-91FD-01E35DD66B87 Q37824617-97920294-294D-43B2-8ACD-B6A64E81E56E Q37886653-340D10E9-9EB9-4C89-8027-6127F237983E Q38044467-FA0F8E72-623D-4A6B-8939-3F67D529C0CA Q38089081-E88A44D3-15F5-4FA7-B928-4BB9ED4CCD55 Q38099556-59191B74-D94A-42C5-99E1-96886778934D Q38177793-689480D9-45BE-455F-A9D5-0EE60C28593F Q38646384-C545D793-27AB-45F7-8D90-BAC03D2FCBA8 Q39027323-4A20D4BA-3F67-4947-905D-865319B59AE4 Q39288750-D16FD571-B454-4A88-9770-E561A5A03685 Q41674222-D95D3C2C-F406-4FE5-91CE-6408734C3334 Q47165421-E4B2EDE4-156F-4E9F-9647-E8D673F852C6 Q47401892-155E8325-9949-4C82-87E8-494806A4C698 Q51668925-6A261161-A26E-442A-8967-5BA90C01EA46 Q53790402-6AE48105-F0DA-4042-9C0B-2B9801C10C3C

P2860

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

http://www.wikidata.org/entity/Q34564174

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@ast

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@en

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@nl

type

label

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@ast

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@en

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@nl

prefLabel

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@ast

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@en

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@nl

P1433

Q34564174-AA78BA55-6387-4632-A927-7B9C0064D1B2

P1476

Q34564174-E21BD26D-01C8-43D5-B261-DB44F352ADBC

P2093

Q34564174-0A8D4769-3A8D-4138-B9B9-D24618EB0062

Q34564174-16A17020-9C54-4A99-935C-F9F75E92274C

Q34564174-2AE408DC-6AEB-4DE7-B106-14E27C39060E

Q34564174-5DAB2F5B-48B8-409D-8C70-60954760BAF9

Q34564174-9BE817BA-134D-4C77-BF01-E5B40CA0115D

Q34564174-BE674783-43DE-4442-95D3-7CD033BD4667

Q34564174-D0A6233C-B714-4F04-A2F0-EB195F485DB7

Q34564174-D6F79914-7CD8-46FD-BA7A-3A9169812464

P2860

Q34564174-3C991CD0-7EF4-4117-B1F6-6F04AFC3CECB

Q34564174-5CC9B789-479E-47ED-840C-D0B01474B551

Q34564174-5FB7F1CF-2783-4D88-9072-EFDCC08768D8

Q34564174-6B998555-998F-4CC8-AAF2-3E6E838019B5

Q34564174-8369700D-F8DC-40CA-998D-EA0BEFDB49AD

Q34564174-C2FC0BDB-C058-4C9D-B0B9-9E31D0746729

Q34564174-EB941F4E-8470-490F-BDF8-DD960B90C816

P304

Q34564174-2878517C-B55C-4CA8-9461-3C06D71F2805

P31

Q34564174-4441074e-9f97-4f28-b2fa-78ba9ff1cbdb

Q34564174-4EE73502-FA24-4193-81AA-69AD98213907

P356

Q34564174-D2219556-D3FA-468F-882F-EF8DA4284830

P407

Q34564174-62B0E94B-768B-47FE-857D-9CFBABD15804

P433

Q34564174-B2D17AB2-9850-4D2A-AA0A-DF64A4EC8912

P478

Q34564174-88AD1C03-34E6-42DF-A11B-FD9DAD4BEAEC

P50

Q34564174-4CA019CA-3A12-420F-8561-7C64E2C528D7

Q34564174-DC60621A-78A7-411E-A3A5-6C96D27F8E9D

P577

Q34564174-FA21D7B2-80D0-45DD-8351-CA8D17FC7790

P5875

Q34564174-A99102E3-F146-4DA1-9F9A-28F27926D222

P698

Q34564174-A8D5B11E-D38E-4C86-A0BA-7A3CC207B5EC

P921

Q34564174-5919FB97-27FD-406F-A67A-6CB956FD8D61

Q34564174-E7435189-EE58-4E8B-8E0B-289B906CC990

P932

Q34564174-92615305-F27E-474D-B1CE-CFDED5DD4906

P356

ARD.2005.040717

P1433

Annals of the Rheumatic Diseases

P1476

Clinical characteristics of pa ...... ments of the Mi-2 beta antigen

@en

P2093

Hengstman GJ

http://www.w3.org/2001/XMLSchema#string

Mosca M

http://www.w3.org/2001/XMLSchema#string

Moutsopoulos HM

http://www.w3.org/2001/XMLSchema#string

Seelig HP

http://www.w3.org/2001/XMLSchema#string

Vencovsky J

http://www.w3.org/2001/XMLSchema#string

Vree Egberts WT

http://www.w3.org/2001/XMLSchema#string

van Engelen BG

http://www.w3.org/2001/XMLSchema#string

van Venrooij WJ

http://www.w3.org/2001/XMLSchema#string

P2860

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

Polymyositis and dermatomyositis (first of two parts).

Myositis-specific autoantibodies: overview and recent developments.

Autoantibody profiles in the sera of European patients with myositis.

Anti-Mi-2 antibodies.

A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

P304

242-245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2005.040717

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Ingrid E Lundberg

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7360772

http://www.w3.org/2001/XMLSchema#string

P698

16410528

http://www.w3.org/2001/XMLSchema#string

P921

P932

1798024

http://www.w3.org/2001/XMLSchema#string